State-of-the-Art Review : Heparin-induced Thrombocytopenia and Thrombosis Syndrome
- 1 July 1998
- journal article
- Published by SAGE Publications in Clinical and Applied Thrombosis/hemostasis
- Vol. 4 (3) , 160-163
- https://doi.org/10.1177/107602969800400303
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Anticoagulation with Novastan®(Argatroban) in Patients with Heparin-Induced Thrombocytopenia and Heparin-Induced Thrombocytopenia and Thrombosis SyndromeSeminars in Thrombosis and Hemostasis, 1997
- Heparin induced thrombocytopeniaEuropean Journal of Vascular and Endovascular Surgery, 1996
- Pathogenicity of IgA and/or IgM antibodies to heparin–PF4 complexes in patients with heparin‐induced thrombocytopeniaBritish Journal of Haematology, 1996
- Heparin-induced thrombocytopenia and fatal thrombosis in a patient with activated protein C resistanceAmerican Journal of Hematology, 1995
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Heparin-associated thrombosis despite normal platelet countsThe Lancet, 1994
- Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.Journal of Clinical Investigation, 1994
- Heparin-associated Thrombocytopenia: A Critical Review and Pooled AnalysisThe Lancet Healthy Longevity, 1993
- Plasmapheresis in the management of heparin-associated thrombocytopenia with thrombosisAmerican Journal of Hematology, 1988
- Immune Endothelial-Cell Injury in Heparin-Associated ThrombocytopeniaNew England Journal of Medicine, 1987